CDH1 and gastric cancer: While the permanent loss of E-cadherin through such mechanisms as LOH coupled with inactivating mutations has been documented in gastric cancer and lobular breast carcinoma, the loss of E-cadherin expression in cancer is most often associated with impermanent mechanisms such as transcriptional silencing, transcriptional repression, or posttranscriptional modifications 40–44.